secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMGC Holdings Inc. (ELAB)
CIK:        0001840563
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001213900-25-055304
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMGC signs LOI to acquire profitable CNC shop; Northstrive advances obesity AI collaboration
--------------------------------------------------------------------------------

- LOI to acquire California CNC shop with $1.4M revenue, $215K adjusted EBITDA in 2024; AS9100D & ISO 9001:2015 certified.
- Target has 35+ years history; third pending acquisition since April 2025, consistent with PMGC's M&A strategy.
- Closing subject to due diligence, approvals, and definitive documentation; non-binding agreement.
- Northstrive initiates Phase II with Yuva Biosciences using MitoNova AI to select small molecules for obesity and cardiac diseases.
- Phase II aims to compile candidates for muscle preservation and metabolic health; builds on prior collaboration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025055304/0001213900-25-055304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840563/000121390025055304/ea0245676-8k_pmgc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-055304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer